
Silence Therapeutics plc bring patent infringement proceedings against Alnylam
Ali Mortazavi, Chief Executive Officer of Silence Therapeutics plc, commented: “We reiterate that we will defend the Silence patent estate where we consider third parties to be infringing the company’s